Risk stratification before thrombolytic therapy in patients with acute myocardial infarction  by Hillis, L.David et al.
(ACC Vol. 16. No . 2
August 1990:3 13 -5
Risk Stratification Before Thrombolytic Therapy in Patients With
Acute Myocardial Infarction
L. DAVID HILLIS, MD, FACC, SANDRA FORMAN, MA,* EUGENE BRAUNWALD, MD, FACCt
AND THE THROMBOLYSIS IN MYOCARDIAL INFARCTION (TIMI) PHASE 11 CO-INVESTIGATORS
Dallas, Texas; Baltimore, Maryland and Boston, Massachusetts
Several studies in the prethrombolytic era on the treatment
of acute myocardial Infarction identified selected variables
liven the patient's history, physical examination, chest
ramlgenogram and electrocardiogram thin mold he used
to estimate mortality In patients with evolving iafardlen .
To extend such assessment to patients receiving throm-
b tytk therapy, this study evaluated the prognostic utility
of several risk factors to the 3,339 patients (2,742 me,
597 wastes, aged 24 to 78 years) enrolled in Phase H of
the Thrnmbolysh in Myocardial Infarction (TIMI) trial .
Before Intravenous tissue plasminagen activator was
given, the presence of each of eight risk factors was
noted: age m70 years, female gender, a history of diabetes
meURas or previous myocardial Infarction, electrocardio-
graphic evidence of evolving anterior infarction or
atrlal fibrillation, evidence on physical examination of mild
pulmonary congestion or hypetension (systolic pressure
Since the inception of the coronary care unit 30 years ago,
several studies have identified easily assessed criteria with
which mortality could be estimated in patients with acute
myocardial infarction. In the 1960s several investigators
(1-3) showed that mortality after myocardial infarction was
related to a number of historical, hemodynamic, radio-
graphic and electrocardiographic (ECG) variables, most of
which could of evaluated within minutes of the patient's
arrival at the hospital . Subsequently other investigators (4,5)
modified some of these variables, but their purpose was
similar to that in the original reports, namely, to identify
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Of the 3,339 patients, the 78 with Women" edema or
ardiagenk shuck were extolled became their flak was
known to be high. Of the resaddeg 3,261, 064 (26%) had
no risk factor (law rink) ; thekr martdfty rate at 6 weeks mas
only 1 .5% . In ceedrad, 2,397 (74%) bad one as more risk
factors (mot low risk)
; of then,
53%
lied
In 6 weds (p <
0.001) . Among those with am or more risk faders, mor-
takyat6weekswasrelated Mdlemmberofriskficlarson
adaritsfoo; those with four or more had a mortality rift at
6 weeks of 17.2% .
Thus, these eight risk factors can be as* remembered
and assessed in patients with myocardial hatoredom who we
candidates
for thrembelytc therapy ad as be sad to
estimate short-leem aarmgty .
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variables with which one could estimate prognosis in the
patient with evolving infarction .
Over the past 10 years thrombolytic therapy has been
shown to improve left ventricular function (6,7) and survival
(8) in patients with acute myocardial infarction when given
within 3 to 4 h of the onset of chest pain . As a result, many
patients with infarction receive thrombolytic therapy shortly
after evaluation. In these patients an assessment of progno-
sis would he helpful. Ideally this assessment should be
simple, quick, noninvasive and easy to employ in the patient
with myocardial infarction who is a candidate for throm-
bolytic therapy. In this study we describe criteria meeting
these requirements and we evaluate their utility in the 3,339
patients enrolled in Phase 11 of the Thrombolysis in Myocar-
dial Infarction (TIMI) trial.
Methods
Study patients. During Phase 11 of the TIMI trial 3,339
patients (2,742 men and 597 women aged 24 to 78 years) with
evolving myocardial infarction and ST segment elevation
were given intravenous recombinant tissue-type plasmino-
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gen activator (rt-PA) within 4 h of the onset of chest pain .
The inclusion and exclusion criteria as well as the details of
patient enrollment have been described (9)
.
Variables assessed. During each patient's evaluation in
the emergency room (before the start of rt-PA therapy), the
presence of pulmonary edema or cardiogenic shock was
noted . Because previous studies (1-3)
have shown that such
patients have a poor prognosis, the 78 patients with these
complications were excluded from analysis. The presence of
each of the following prespecifted risk factors was noted: age
33670 years, a history of previous infarction, ECG evidence of
evolving anterior infarction or atria] fibrillation, evidence on
physical examination of moderate pulmonary congestion
(rates heard in more than one third of the lung fields) or the
combination of hypotension (systolic pressure <100 mm Hg)
and sinus tachycardia (heart rate >100 bears/min).
Treatment. All patients received intravenous n-PA (150
mg in 6 h in
503 patients, 100 mg in 6 h in 2,758) followed by
intravenous heparin (for 5 days) and oral aspirin (80 mg/day
for 5 days, 325 mg/day thereafter) (9).
Each patient was then
managed according to either an invasive strategy (n = 1,641)
with coronary arteriography and angioplasty (if appropriate)
18 to 48 h after thrombolytic therapy or a conservative
strategy (n = 1,620) in which arteriography and angioplasty
were performed only in those with spontaneous or exercise-
induced ischemia. Because the two groups were similar in
mortality
at 6 weeks, in rate of reinfarctian and in left
ventricular ejection fraction (9) they were considered to-
gether for the purposes of data analysis . Patients with none
of the risk factors were designated "low risk," whereas
those with one or more were designated "not low risk ."
Statistical analyses. Prospectively, the presence of each
of the aforementioned six risk factors was noted . After the
completion of the trial, two additional risk factors (female
gender and a history of diabetes mellitus) were considered .
These risk factors were chosen because each had been used
previously (1-3)
to estimate mortality after infarction and
each could be assessed quickly and noninvasively when the
patient arrived at the hospital. The mortality at 6 weeks for
each of the eight risk factors was determined, as was the
mortality when one or more of these risk factors was
present, In addition, the mortality at 6 weeks for each risk
factor and for the risk factors in combination was calculated .
A chi-square test was used to compare patients with no risk
factors and those with one or more risk factors . A logistic
regression analysis was performed with mortality at 6 weeks
as the dependent variable and the eight risk factors as
independent variables . All statistical analyses were per-
formed using BMDP statistical package programs (10) . For
all analyses a p value <0.01 was considered significant .
Results
Mortality of low risk and not low risk patients
. Of the 3,339
patients, 78 had pulmonary edema or cardiogenic shock
;
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Table 1 . Mortality at 6 Weeks for Each of the Eight Risk Factors
in 3,261 Patients-
'uetenty .eahtpatients with cardiogenic shook or pslntunary edema were
eucloded.
their mortality rate at 6 weeks was 33.3% and they were
excluded from analysis. Of the remaining 3,261 patients, 139
(4.3%) died within 6 weeks . Of the 3,261, 864 (26%) had no
risk factor (low risk) ; at 6 weeks 13 (1,5%) had died . In
contrast, 2,397 patients (74%) bad one or more risk factors
(not low risk); at 6 weeks 126 (5 .3%) had died (p < 0.001).
Relation of morality to number of risk factors. Table I
shows the number of patients With each of the eight risk
factors and the mortality associated with each. These data
were similar whether patients were treated according to a
conservative strategy or an invasive one . Among the 2,397
patients with one or more risk factors, the mortality at 6
weeks was related to the number of risk factors present on
admission (Table 2).
By logistic regression analysis, the risk factors that were
associated most strongly with mortality at 6 weeks were age
a70 years, hypotension and sinus tachycordia and anterior
infarction (Table 3) .
Discussion
Previous criteria for aft aft proptoals In padenta wtY
acute
myocardial
intarciton . The treatment of patients with
myocardial infarction was altered substantially with the
inception of the coronary care unit in the 1960s . In this
setting, ECG monitoring and the suppression of ventricular
tachyarrhythmias led to a marked decline in fatal arrhythmic
Table 2. Mortality at 6 Weeks According to Number of Risk
Factors Present
No . of Risk No . of Deaths Mortality
Factors No. of Patients Within 6 Weeks Rue (%)
0 a64 13 1.5
1 1,384
32
2.3
z 689 48 7.0
3 231 30 13.0
N 93 16 17.2
Risk Factor
No. of Patients With
Risk Factor (%)
No. of Deaths in
6 Weeks (%)
Age a70 years
374 (11 .5) 42 (11 .2)
Previous infarction 456 (13.7) 36(7.9)
Anterior infarction 1 .691 (51 .5) 94(5.6)
Atria) fibrillation 66(2.0) 7(10.6)
Rake in more than one
third of lung fields
105 (3.2) 13 (12.4)
Hypotension and sinus
tachycardia
150 (4.8) 16 (10.0
Female gender
577 (17.7)
41(7
.1)
Diabetes melluus 425 (13.0) 36(8.5)
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Tinkle 3. Logistic Regression Analysis for the Eight Risk Factors
events . Such monitoring also provided an opportunity to
assess the factors that influence prognosis after infarction .
Peel et al. (1) showed that prognosis for the 4 weeks after
infarction was influenced by the patient's age, gender, his-
tory ofischemic heart disease, extent of ECG alterations and
the presence of shock, congestive heart failure or rhythm
and conduction disturbances. For each variable a numeric
score was calculated, with a higher number signifying a more
abnormal value. At the time of admission a total score was
tabulated from which the subject's mortality at 4 weeks was
estimated
. Although this so-called Pal index offered useful
prognostic information, it was too complicated for the prac-
ticing physician to use without referring to a written text .
In a study of 250 patients with myocardial infarction, Killip
and Kimball (2) showed that incidence of life-threatening
alrhythmias and mortality were related to the extent of left
ventricular dysfunction. Thus, 36% of patients without conges-
tive heart failure had life-threatening arrhythmias and 6% died
m the hospital (class I); 46%of those with mild heart failure had
arrhythm ias and 17% died (class U) ; 73% of patients with
severe heart failure manifested life-threatening arrhythmias
and 38% died (class III) ; and 94% of those with cardiogenic
shock had
arrhythmina
and 81% died (class IV) . This classifi-
cation scheme became very popular, probably in large part
because of its simplicity and ease of application .
Norris et al . (3) used discriminant analysis in 757 patients
with myocardial infarction to derive a so-called coronary
prognostic index. This index was constructed from numeric
weightings of six variables : patient age, history of ischemic
heart disease, ECG location of infarction, systolic arterial
pressure, radiographic heart size and extent of pulmonary
congestion . As did the scheme of Peel et al . (1), this index
required that each of the variables be given a numeric score,
after which the scores were summed
. With this index the 757
patients were divided into several groups with increasing
mortality rates from 3% to as high as 78% .
Criteria for risk strMificadon deter bed ks the present study
:
adwohtgesand reraYs In this study we describe a number of
risk factors that can be used to estimate short-term prognosis
reliably in patients with myocardial infarction receiving
thrombolytic therapy. The risk factors are easy to remember
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and therefore can be used without consulting a textbook or
manuscript. One simply determines the presence or absence
of each risk factor; it is not necessary to assign a numeric
score to each variable. The risk factors are usually deter-
mined during the routine evaluation that precedes throm-
bolytic therapy within minutes
ofthe patient's presentation .
No waiting is required for the results of a chest radiograph or
of hemodynamic data available only with invasive monitor-
ing .
It is established that pulmonary edema and cardiogenic
shock are associated with a poor prognosis even with thcom-
bolytic therapy. In Phase 11 of the TIMI trial they were
associated with a 6 week mortality rate of 33 .3%.These com-
plications of myocardial infarction were not considered along
with the eight risk factors in this analysis because they exert
such an obvious effect . In patients without cardiogenic shock
or pulmonary edema,
if
now of the eight risk factors was
present, the patient was said to be at low risk and the
short.term outlook was excellent (survival rate at 6 weeks,
98.5%). In contrast, if one or more risk factors were present.
the patient was designated "not low risk" and the survival rate
at 6 weeks was lower (94.7%) (p < 0.001)
. Furthermore,
survival was related to the number of risk factors present on
admission, so that the mortality rate 6 weeks after infarction
was 17 .2% in patients with four ormore risk factors (Table 2) .
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Risk Factor Coefficient P Value
Apx70yeots -1 .0470 <0.m1
Previous
infatdion -0.6255 0.002
Anlniorinf-lion -0.6120 <000t
Acrid sbriaation -0.7854 0.062
Roles to morn than one
third of lung fields
-0.8067 0.012
Hypotension and sinus
to hycndia
-0 .9799 <0.001
Female gender -0
.4284
0031
Diabetes
mellitus
-0.6404 0
.002
